|
CTMX
CytomX Therapeutics, Inc.
CTMX · Q2 FY2024
|
Q2 FY2024 |
|
CTMX Q2 FY2024 transcript
|
|
DXC
DXC Technology Co
DXC · Q1 FY2025
|
Q1 FY2025 |
|
DXC Q1 FY2025 transcript
|
|
DOCS
Doximity, Inc.
DOCS · Q1 FY2025
|
Q1 FY2025 |
|
DOCS Q1 FY2025 transcript
|
|
DCO
Ducommun Inc /De/
DCO · Q2 FY2024
|
Q2 FY2024 |
|
DCO Q2 FY2024 transcript
|
|
U
Unity Software Inc.
U · Q2 FY2024
|
Q2 FY2024 |
|
U Q2 FY2024 transcript
|
|
FOUR
Shift4 Payments, Inc.
FOUR · Q2 FY2024
|
Q2 FY2024 |
|
FOUR Q2 FY2024 transcript
|
|
KODK
Eastman Kodak Co
KODK · Q2 FY2024
|
Q2 FY2024 |
|
KODK Q2 FY2024 transcript
|
|
HCI
HCI Group, Inc.
HCI · Q2 FY2024
|
Q2 FY2024 |
|
HCI Q2 FY2024 transcript
|
|
NOTE
FiscalNote Holdings, Inc.
NOTE · Q2 FY2024
|
Q2 FY2024 |
|
NOTE Q2 FY2024 transcript
|
|
CQP
Cheniere Energy Partners, L.P.
CQP · Q2 FY2024
|
Q2 FY2024 |
|
CQP Q2 FY2024 transcript
|
|
REZI
Resideo Technologies, Inc.
REZI · Q2 FY2024
|
Q2 FY2024 |
|
REZI Q2 FY2024 transcript
|
|
HIPO
Hippo Holdings Inc.
HIPO · Q2 FY2024
|
Q2 FY2024 |
|
HIPO Q2 FY2024 transcript
|
|
NEPH
Nephros Inc
NEPH · Q2 FY2024
|
Q2 FY2024 |
|
NEPH Q2 FY2024 transcript
|
|
NVAX
Novavax Inc
NVAX · Q2 FY2024
|
Q2 FY2024 |
|
NVAX Q2 FY2024 transcript
|
|
SENS
Senseonics Holdings, Inc.
SENS · Q2 FY2024
|
Q2 FY2024 |
|
SENS Q2 FY2024 transcript
|
|
SPB
Spectrum Brands Holdings, Inc.
SPB · Q3 FY2024
|
Q3 FY2024 |
|
SPB Q3 FY2024 transcript
|
|
OABI
OmniAb, Inc.
OABI · Q2 FY2024
|
Q2 FY2024 |
|
OABI Q2 FY2024 transcript
|
|
WHF
WhiteHorse Finance, Inc.
WHF · Q2 FY2024
|
Q2 FY2024 |
|
WHF Q2 FY2024 transcript
|
|
UP
Wheels Up Experience Inc.
UP · Q2 FY2024
|
Q2 FY2024 |
|
UP Q2 FY2024 transcript
|
|
IHRT
iHeartMedia, Inc.
IHRT · Q2 FY2024
|
Q2 FY2024 |
|
IHRT Q2 FY2024 transcript
|
|
CNNE
Cannae Holdings, Inc.
CNNE · Q2 FY2024
|
Q2 FY2024 |
|
CNNE Q2 FY2024 transcript
|
|
G
Genpact LTD
G · Q2 FY2024
|
Q2 FY2024 |
|
G Q2 FY2024 transcript
|
|
RDVT
Red Violet, Inc.
RDVT · Q2 FY2024
|
Q2 FY2024 |
|
RDVT Q2 FY2024 transcript
|
|
SMRT
SmartRent, Inc.
SMRT · Q2 FY2024
|
Q2 FY2024 |
|
SMRT Q2 FY2024 transcript
|